IL17A and neoplasm: Recent research shows that gut γδT cells, which are IFN‐γ‐secreting, but not IL‐17–secreting, are glycolytic and exert antitumor activity, and analysis of human samples also pointed to glycolytic γδT cells that were preferentially found in the tumor‐adjacent areas [38].